IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

COSSU, MARIA VITTORIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.087
EU - Europa 964
AS - Asia 414
SA - Sud America 39
AF - Africa 33
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.553
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.020
GB - Regno Unito 282
CN - Cina 212
IT - Italia 205
SE - Svezia 106
DE - Germania 100
CA - Canada 57
FR - Francia 45
IN - India 45
ES - Italia 38
IE - Irlanda 37
HK - Hong Kong 35
NL - Olanda 33
TR - Turchia 29
JP - Giappone 26
CH - Svizzera 21
BE - Belgio 20
DK - Danimarca 20
KR - Corea 16
BR - Brasile 14
FI - Finlandia 14
VN - Vietnam 14
AU - Australia 13
AR - Argentina 11
CO - Colombia 10
MX - Messico 9
TW - Taiwan 9
GR - Grecia 8
SG - Singapore 8
ET - Etiopia 7
UA - Ucraina 7
ZA - Sudafrica 7
RU - Federazione Russa 6
TH - Thailandia 6
BW - Botswana 5
CZ - Repubblica Ceca 5
CL - Cile 4
RO - Romania 4
UG - Uganda 4
ID - Indonesia 3
IR - Iran 3
PL - Polonia 3
TZ - Tanzania 3
BG - Bulgaria 2
BJ - Benin 2
KE - Kenya 2
LB - Libano 2
MW - Malawi 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
SA - Arabia Saudita 1
Totale 2.553
Salva come PNG Salva come JPEG
Città #
Southend 195
Chandler 161
Houston 101
Fairfield 83
Milan 83
Ashburn 63
Frankfurt am Main 56
Redwood City 53
Seattle 53
Beijing 43
Woodbridge 43
Princeton 40
Ann Arbor 39
Toronto 39
Wilmington 38
Dublin 33
Cambridge 28
Hong Kong 27
Nanjing 25
Boardman 22
Shanghai 22
Bengaluru 17
Brussels 16
Dearborn 16
Istanbul 15
Des Moines 14
Rotterdam 14
Dong Ket 13
Phoenix 13
London 11
Helsinki 10
Duncan 9
New York 9
Nihon'odori 9
Fremont 8
Munro 8
Rome 8
Santiago de Cali 8
Shenyang 8
Athens 7
Barcelona 7
San Diego 7
Jinan 6
Mumbai 6
Ottawa 6
Seoul 6
Taipei 6
Turin 6
Central District 5
Cergy 5
Chiang Mai 5
Duisburg 5
Gaborone 5
Los Angeles 5
Washington 5
Wenzhou 5
Zurich 5
Bartlesville 4
Berlin 4
Glenwood 4
Guangzhou 4
Haikou 4
Heusenstamm 4
Manchester 4
Molina de Segura 4
Nanchang 4
Nora 4
Silver Spring 4
Sydney 4
Talamanca de Jarama 4
Tappahannock 4
Waddinxveen 4
Wageningen 4
Ankara 3
Augusta 3
Buenos Aires 3
Bühl 3
Changsha 3
Copenhagen 3
Dar es Salaam 3
Edinburgh 3
Groningen 3
Kunming 3
Langley 3
Madrid 3
Ostermundigen 3
Oxford 3
Prague 3
Tijuana 3
Warsaw 3
Waverly 3
Yongin-si 3
Zhengzhou 3
Altamura 2
Bakirkoey 2
Bellevue 2
Brasília 2
Brisbane 2
Catania 2
Chongqing 2
Totale 1.693
Salva come PNG Salva come JPEG
Nome #
Long term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicenter cohort of HIV1-infected, virologically suppressed patients 665
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 165
Maraviroc reduces arterial stiffness in PI-treated HIV-infected patients 151
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48weeks' observational data 145
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status 139
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 132
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 122
An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents 118
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 116
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 116
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 107
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 94
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 92
Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects : an Italian cohort 91
Dolutegravir plus rilpivirine as a switch option in cART-experienced patients : 96-week data 77
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 66
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 62
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study 54
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 49
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 43
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 35
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects 31
Analyzing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicenter cohort of virologically-suppressed PLWHIV 24
High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy 3
Detection and typization of HPV genotypes in subjects with oral and upper respiratory tract lesions, Milan, Italy 1
Totale 2.698
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201963 0 0 0 0 0 0 0 0 0 13 22 28
2019/2020541 24 9 12 34 32 142 61 41 55 57 46 28
2020/2021477 47 27 17 28 33 76 56 43 39 41 31 39
2021/2022464 48 27 30 27 28 38 39 22 69 40 18 78
2022/2023543 57 78 53 62 30 88 12 45 42 14 38 24
2023/2024394 29 38 31 54 123 50 12 25 13 19 0 0
Totale 2.698